Project Grant HT94252510484
Award Date
9/1/25
Completion Date
8/29/29
Dollars Obligated
$2.3M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Aurora, CO 80045, USA
Similar Awards
The Defense Health Agency awarded a $1,260,839 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to The Regents of the University of Colorado, doing business as the University of Colorado-Denver. The grant, effective May 1, 2025 through April 30, 2029, will support research targeting EHMT1/2 to overcome therapy-resistant ovarian cancer. As a prominent public research university, the University of Colorado-Denver leverages its expertise across multiple...
The Defense Health Agency awarded a $320,000 Project Grant to the Regents of the University of Colorado Denver under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from August 1, 2023 to July 31, 2025 to determine the mechanisms underlying remyelination by surviving oligodendrocytes. The research aims to advance understanding of how the central nervous system repairs myelin sheaths, with potential implications for treating multiple...
This $3,800,334 federal Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) will fund The Regents of the University of Colorado to conduct research to improve maternal mental health in military-affiliated pregnant women through the effectiveness of a smart bassinet intervention. The project will run from June 2024 to June 2028 and aims to develop and evaluate an innovative technological solution to address mental health...
This Project Grant from the Defense Health Agency provides $349,939 to the University of Colorado Denver under the Military Medical Research and Development federal grant program (CFDA 12.420) from February 1, 2023 to January 31, 2026. The grant funds research on transfemoral osseointegrated prosthesis limb-load symmetry training. As the program description notes, the Military Medical Research and Development program supports basic, applied, and advanced biomedical research to improve military...
The federal Project Grant award of $1,225,783 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports the development of a fully automated deep learning-based framework for segmentation and treatment response assessment of lesions on PSMA PET/CT in prostate cancer. This research, conducted by the University of Colorado-Denver, aims to transform healthcare for military service members, veterans, and the broader public by advancing innovative...
The University of Colorado Denver was awarded a $3,067,768 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420) to investigate the mechanisms underlying brain metastatic progression in ER+ breast cancer. The three-year award running from September 1, 2022 to August 31, 2025 will support research into medical solutions for the battlefield by transforming healthcare through innovative and impactful...
The federal Project Grant award of $2,271,024.00 was provided by the Defense Health Agency, under the Military Medical Research and Development (CFDA 12.420) federal grant program, to the University of Colorado-Denver. The award, effective November 1, 2024, supports a four-year research project to improve understanding of next-generation immunotherapy responses in metastatic uveal melanoma. The University of Colorado-Denver, a major public research university with a strong focus on medical...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $780,000.00 to The Regents of the University of Colorado, doing business as the University of Colorado-Denver, to support research on "An Unconventional Pathway to Melanoma Development and Prevention". The research aims to investigate innovative approaches to address melanoma, a serious form of skin cancer, with the goal of improving...
This $2,488,002.00 Project Grant from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports a multi-year research effort by the University of Colorado-Denver to develop biomarkers for detecting acute, subacute, and chronic organ injury following neonatal congenital heart disease surgery. The research aims to improve diagnostic capabilities and treatment outcomes for this patient population. The award runs from April 1, 2024 to March 31, 2028, and...
The U.S. Department of the Army Medical Command awarded a $1,363,999 project grant under the Military Medical Research and Development (CFDA 12.420) program to the University of Colorado-Denver. The grant, titled "Living Well with Brain Cancer (LWBC): A Group-Based Intervention to Promote Whole-Person Well-Being," will fund research to develop and evaluate a group-based intervention to improve the overall well-being of individuals living with brain cancer. The University of...